CRISPR And Cas Gene Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR Will the CRISPR And Cas Gene Market Achieve During 2025–2034, and What Does It Indicate?
The market size of crispr and cas gene has seen a rapid expansion in the past few years. The market, which stood at $3.99 billion in 2024, is expected to increase to $4.85 billion in 2025, representing a compound annual growth rate (CAGR) of 21.7%. This notable surge during the historical period is linked to factors such as heightened consumer consciousness, a change in consumer preferences, the impact of celebrity endorsements, the emergence of veganism, and the growing sway of social media.
In the upcoming years, significant expansion is anticipated in the market size of crispr and cas gene, escalating to $10.81 billion in 2029 with a compound annual growth rate (CAGR) of 22.2%. This surge in growth throughout the forecast duration is credited to the worldwide enlargement of bans, burgeoning conscious consumerism, the introduction of fresh brands, efforts to educate the consumer, and beauty inclusivity. Key trends projected for this period encompass advancements in technology, inventions in product, the emergence of the circular beauty economy, progress in the men’s grooming sector, and a focus on social justice and ethical sourcing.
What Industry-Specific Factors Are Fueling the Growth of the crispr and cas gene Market?
The escalating emphasis on tailored treatments is predicted to drive the expansion of the CRISPR and Cas gene markets. Tailored treatments mean a healthcare model that directs choices about diagnosis, treatment, and disease prevention based upon a person’s unique genetic makeup. CRISPR and the Cas gene, especially Cas9, play a crucial role in personalized medicine. They allow exact amendments to a person’s genetic data, providing potential for innovative developments in creating personalized therapies for genetic disorders, cancer, and different medical conditions. For example, in January 2023, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), as reported by the US-based professional association, the Personalized Medicine Coalition, gave authorization to 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, about 34%, or 12 of them, are categorized as personalized medicines by the Personalized Medicine Coalition (PMC). So, the increasing requirement for personalized treatment will escalate the growth of the CRISPR and Cas gene markets.
Request Your Free CRISPR And Cas Gene Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13632&type=smp
Who Are the Key Firms Paving the Way for Growth in the CRISPR And Cas Gene Market?
Major companies operating in the Crispr and cas gene market report are:
• F. Hoffmann-La Roche AG_x000D_
• Thermo Fisher Scientific Inc._x000D_
• AstraZeneca plc._x000D_
• Danaher Corporation_x000D_
• Quest Diagnostics_x000D_
What Are the Most Influential Trends Currently Shaping the CRISPR And Cas Gene Market?
Key players within the CRISPR and Cas gene markets, with the aim of enhancing their product range and acquiring a competitive upper hand, are developing cutting-edge products like CRISPR-based cell-based gene therapies. These therapies leverage CRISPR gene-editing technology to alter or rectify the genetic material inside cells, thereby offering a focused, potentially groundbreaking method to address genetic disorders, illnesses, and various medical conditions at a cellular level. To illustrate, Vertex Pharmaceuticals Incorporated, an American biopharmaceutical firm, gained approval for CASGEVY (exagamglogene autotemcel [exa-cel]) from the U.S. Food and Drug Administration (FDA) in December 2023. CASGEVY, a gene therapy formulated using CRISPR/Cas9 genome editing, is intended to manage sickle cell disease (SCD) in individual aged 12 or over who frequently suffer from vaso-occlusive crises. This first-of-its-kind treatment could possibly serve as a one-time life-altering therapy for appropriate sickle cell patients. As CASGEVY administration requires unique expertise in stem cell transplantation, Vertex is partnering with seasoned institutions to establish a network of independently owned, approved treatment centers (ATCs) across the United States for providing CASGEVY to patients.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report
What Are the Major Segments of the CRISPR And Cas Gene Market and Their Role in Driving Growth?
The crispr and cas gene market covered in this report is segmented –
1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types
2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis
3) By Application: Clinical, Financial, Operational And Administrative
4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Kits And Enzymes: CRISPR Kits, Cas Enzymes, Grna Synthesis Kits
2) By Libraries: CRISPR Libraries For Gene Knockout, CRISPR Libraries For Gene Activation, Sgrna Libraries
3) By Design Tools: Online Design Platforms, Software For CRISPR Guide RNA Design, Custom Design Services
4) By Antibodies: Antibodies For Cas Proteins, Antibodies For Detection Of Edited Cells, Secondary Antibodies For Immunoassays
5) By Other Product Types: Delivery Systems, CRISPR-Related Consumables, Control Plasmids And Reagents
Which Regions Are Essential for the Growth of the CRISPR And Cas Gene Market?
North America was the largest region in the CRISPR and Cas gene market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Scope and Reach of the CRISPR And Cas Gene Market Defined?
CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, and the Cas (CRISPR-associated) gene, particularly Cas9, constitute a powerful gene-editing technology. This system enables precise modifications to DNA sequences, revolutionizing genetic research, biotechnology, and potential medical applications.
Browse Through More Similar Reports By The Business Research Company:
Cell & Gene Therapy Manufacturing Services Global Market Report 2024
Gene Delivery Technologies Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
Nucleic Acid Based Gene Therapy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
